Alex represents Northstar Ventures, a key investor in Arquer. He joined Northstar in September 2004 following a series of senior commercial roles in the biotechnology sector, including Cybersense, Compugen, SDI Europe, EnSys Europe, and Archaeus. Alex completed a Ph.D. in Microbiology before spending three years in London as a stockbroker for UBS Phillips and Drew.
This person is not in the org chart
This person is not in any teams
This person is not in any offices